Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women.

@article{Grnbaek2004SerumIG,
  title={Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women.},
  author={H Gr\onbaek and Allan Flyvbjerg and Lene Mellemkjaer and Anne Tj\onneland and J. Tind Christensen and Henrik Toft S\orensen and Kim Overvad},
  journal={Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology},
  year={2004},
  volume={13 11 Pt 1},
  pages={1759-64}
}
BACKGROUND Studies have shown a positive association between serum insulin-like growth factor (IGF)-I and breast cancer risk in premenopausal but not postmenopausal women. IGF-II and estrogen receptor (ER) status has never been investigated. We examined the association between IGF-I, IGF-II, IGF binding protein (IGFBP)-2, IGFBP-3, and IGFBP-3 protease activity and breast cancer risk in postmenopausal women, taking ER status of the breast cancer into consideration. METHODS We conducted this… CONTINUE READING
18 Citations
28 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 28 references

Prospective study of IGF-I, IGFbinding proteins, and breast cancer risk, in northern and southern Sweden

  • R Kaaks, E Lundin, S Rinaldi
  • Cancer Causes Control
  • 2002
Highly Influential
5 Excerpts

Similar Papers

Loading similar papers…